Chen F, Xu K, Han Y, Ding J, Ren J, Wang Y
Front Immunol. 2025; 15():1503087.
PMID: 39776917
PMC: 11703726.
DOI: 10.3389/fimmu.2024.1503087.
Nikiforova A, Baburina Y, Borisova M, Surin A, Kharechkina E, Krestinina O
Cells. 2023; 12(19).
PMID: 37830628
PMC: 10572550.
DOI: 10.3390/cells12192414.
Bernardi P, Gerle C, Halestrap A, Jonas E, Karch J, Mnatsakanyan N
Cell Death Differ. 2023; 30(8):1869-1885.
PMID: 37460667
PMC: 10406888.
DOI: 10.1038/s41418-023-01187-0.
Neginskaya M, Pavlov E
DNA Cell Biol. 2023; 42(8):481-487.
PMID: 37311169
PMC: 10460960.
DOI: 10.1089/dna.2023.0171.
Robichaux D, Harata M, Murphy E, Karch J
J Mol Cell Cardiol. 2022; 174:47-55.
PMID: 36410526
PMC: 9868081.
DOI: 10.1016/j.yjmcc.2022.11.003.
Structure and Gating Behavior of the Human Integral Membrane Protein VDAC1 in a Lipid Bilayer.
Najbauer E, Movellan K, Giller K, Benz R, Becker S, Griesinger C
J Am Chem Soc. 2022; 144(7):2953-2967.
PMID: 35164499
PMC: 8874904.
DOI: 10.1021/jacs.1c09848.
The mitochondrial permeability transition: Recent progress and open questions.
Bernardi P, Carraro M, Lippe G
FEBS J. 2021; 289(22):7051-7074.
PMID: 34710270
PMC: 9787756.
DOI: 10.1111/febs.16254.
Physiological Ca Transients Versus Pathological Steady-State Ca Elevation, Who Flips the ROS Coin in Skeletal Muscle Mitochondria.
Li A, Yi J, Li X, Zhou J
Front Physiol. 2020; 11:595800.
PMID: 33192612
PMC: 7642813.
DOI: 10.3389/fphys.2020.595800.
Recent progress in the use of mitochondrial membrane permeability transition pore in mitochondrial dysfunction-related disease therapies.
Cui Y, Pan M, Ma J, Song X, Cao W, Zhang P
Mol Cell Biochem. 2020; 476(1):493-506.
PMID: 33000352
DOI: 10.1007/s11010-020-03926-0.
The new role of FF ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection.
Mnatsakanyan N, Jonas E
Exp Neurol. 2020; 332:113400.
PMID: 32653453
PMC: 7877222.
DOI: 10.1016/j.expneurol.2020.113400.
ATP synthase c-subunit ring as the channel of mitochondrial permeability transition: Regulator of metabolism in development and degeneration.
Mnatsakanyan N, Jonas E
J Mol Cell Cardiol. 2020; 144:109-118.
PMID: 32461058
PMC: 7877492.
DOI: 10.1016/j.yjmcc.2020.05.013.
A mitochondrial megachannel resides in monomeric FF ATP synthase.
Mnatsakanyan N, Llaguno M, Yang Y, Yan Y, Weber J, Sigworth F
Nat Commun. 2019; 10(1):5823.
PMID: 31862883
PMC: 6925261.
DOI: 10.1038/s41467-019-13766-2.
Negative Conditioning of Mitochondrial Dysfunction in Age-related Neurodegenerative Diseases.
Selvaraji S, Poh L, Natarajan V, Mallilankaraman K, Arumugam T
Cond Med. 2019; 2(1):30-39.
PMID: 31058265
PMC: 6497175.
Dynamics of the mitochondrial permeability transition pore: Transient and permanent opening events.
Boyman L, Coleman A, Zhao G, Wescott A, Joca H, Greiser B
Arch Biochem Biophys. 2019; 666:31-39.
PMID: 30930285
PMC: 6538282.
DOI: 10.1016/j.abb.2019.03.016.
Real-time local oxygen measurements for high resolution cellular imaging.
Boyman L, Williams G, Wescott A, Leach J, Kao J, Lederer W
J Mol Cell Cardiol. 2018; 127:97-104.
PMID: 30528909
PMC: 6613206.
DOI: 10.1016/j.yjmcc.2018.11.021.
Properties of the Permeability Transition of Pea Stem Mitochondria.
De Col V, Petrussa E, Casolo V, Braidot E, Lippe G, Filippi A
Front Physiol. 2018; 9:1626.
PMID: 30524297
PMC: 6262314.
DOI: 10.3389/fphys.2018.01626.
Mitochondrial permeability transition pore: a potential drug target for neurodegeneration.
Kalani K, Yan S, Yan S
Drug Discov Today. 2018; 23(12):1983-1989.
PMID: 30081095
PMC: 6449145.
DOI: 10.1016/j.drudis.2018.08.001.
Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target.
Camara A, Zhou Y, Wen P, Tajkhorshid E, Kwok W
Front Physiol. 2017; 8:460.
PMID: 28713289
PMC: 5491678.
DOI: 10.3389/fphys.2017.00460.
VDAC regulates AAC-mediated apoptosis and cytochrome release in yeast.
Trindade D, Pereira C, Chaves S, Manon S, Corte-Real M, Sousa M
Microb Cell. 2017; 3(10):500-510.
PMID: 28357318
PMC: 5348984.
DOI: 10.15698/mic2016.10.533.
Anion Channels of Mitochondria.
Ponnalagu D, Singh H
Handb Exp Pharmacol. 2016; 240:71-101.
PMID: 27783269
PMC: 5855116.
DOI: 10.1007/164_2016_39.